News Amphastar Pharmaceuticals, Inc.

Equities

AMPH

US03209R1032

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
38.65 ^USD	-3.50%		-3.74%	-37.51%

Mar. 13	Transcript : Amphastar Pharmaceuticals, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 11:15 AM
Mar. 08	Amphastar Pharmaceuticals Insider Sold Shares Worth $842,883, According to a Recent SEC Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	AQ
Transcript : Amphastar Pharmaceuticals, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 11:15 AM	Mar. 13
Amphastar Pharmaceuticals Insider Sold Shares Worth $842,883, According to a Recent SEC Filing	Mar. 08	MT
JPMorgan Initiates Amphastar Pharmaceuticals With Overweight Rating, Price Target is $60	Mar. 05	MT
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023	Feb. 29	AQ
Sector Update: Health Care Stocks Advance Premarket Thursday	Feb. 29	MT
Amphastar Pharmaceuticals Q4 Adjusted Earnings, Revenue Rise	Feb. 29	MT
Transcript : Amphastar Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Amphastar Pharmaceuticals, Inc. Reports Impairment of Long-Lived Assets for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Amphastar: Q4 Earnings Snapshot	Feb. 28	AQ
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Posts Q4 EPS $0.88, vs. Street Est of $0.91	Feb. 28	MT
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Reports Q4 Revenue $178.1M, vs. Street Est of $173.3M	Feb. 28	MT
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024	Feb. 21	AQ
High-dose opioid reversal spray no better than lower dose in field, US study finds	Feb. 08	RE
Amphastar Pharmaceuticals Insider Sold Shares Worth $7,171,768, According to a Recent SEC Filing	Jan. 11	MT
Amphastar Pharmaceuticals Insider Sold Shares Worth $12,798,708, According to a Recent SEC Filing	Jan. 11	MT
Transcript : Amphastar Pharmaceuticals, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 09:00 AM	Jan. 10
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	AQ
MannKind Restructures Supply Agreement with Amphastar Pharmaceuticals	Dec. 28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Amphastar Pharmaceuticals, Inc.

Equities

AMPH

US03209R1032

Summary

Filters